Blue Note Therapeutics Raises $26.25 Million in Series A Financing

05 Mar, 2021

Blue Note Therapeutics Raises $26.25 Million in Series A Financing
Photo by Victoria Heath on Unsplash

– Blue Note Therapeutics announced a $26.25m Series A financing round.
– The round was led by JAZZ Venture Partners and joined by Summer VC.
– Blue Note Therapeutics is dedicated to serving patients suffering from cancer-related distress.
– The capital will also support the development of Blue Note’s pipeline assets.

Health Care Medical North America Therapeutics
Crunchbase icon

Content report

The following text will be sent to our editors: